;

Abzena Receives Growth Capital Investment from Newly Launched Biospring Partners

30/07/2020

Abzena, a leading global partnership research organization providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a $10M investment of growth capital from Biospring Partners, a New York based investment firm.

The new capital will allow Abzena to accelerate its growth plans. Abzena drove 80% revenue growth and tripled GMP manufacturing capacity in the first half of 2020. “The investment by Biospring Partners is further validation that the Abzena integrated model is the future of biologics drug development and manufacturing,” said Jonathan Goldman MD, CEO of Abzena. “Michelle Dipp and Jennifer Lum founded Biospring based upon their deep expertise in life sciences and technology industries. Abzena will benefit from Biospring’s access to a broad network of potential customers and their expertise in building and operating growth stage companies. Access to new customer partners and operating expertise is essential for the continuing growth of the company.”

“It is an exciting time to join Abzena’s board. Abzena is uniquely positioned to take advantage of the global market opportunity for large molecules as the biopharmaceutical industry increasingly outsources development and manufacturing,” said Dr. Dipp. “Abzena is the industry leader for the comprehensive and integrated development of biologics and ADCs.”

“We are thrilled to have Dr. Dipp join the board of Abzena, one of our portfolio companies,” said Nick O’Leary of Welsh, Carson, Anderson and Stowe. “Dr. Dipp’s expertise in life sciences and the additional capital Biospring has invested will allow Abzena to continue its global growth and market reach.”

 

Article sourced from: https://abzena.com/news/abzena-receives-growth-capital-investment-from-newly-launched-biospring-partners/
Published on: 28/07/20

Contact us

BABRAHAM RESEARCH
CAMPUS

(+44) 1223 496 000
info@babraham.co.uk

Babraham Bioscience Technologies Ltd
Babraham Research Campus
Cambridge
CB22 3AT, United Kingdom

Press Enquiries

Limewash
01223 813 557
info@limewash.co.uk

Subscribe to our mailing list

Please enter your first name
Please enter your surname
Please enter your email address
Submit
; ;